Merck (MRK) Short-term Investments (2009 - 2026)

Merck (MRK) has reported Short-term Investments for 17 consecutive years, with $292.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments fell 52.52% year-over-year to $292.0 million in Q2 2026; TTM through Jun 2026 was $292.0 million, a 52.52% decrease from a year earlier, with the FY2024 full-year figure at $447.0 million, up 77.38% from the prior year.
• Short-term Investments was $292.0 million for Q2 2026 at Merck, down from $375.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $718.0 million in Q2 2023 and troughed at $40.0 million in Q1 2024.
• A 5-year average of $356.7 million and a median of $373.5 million in 2022 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 94.12% in 2024 and jumped 1397.5% in 2025, its largest moves.
• Over 5 years, Short-term Investments stood at $498.0 million in 2022, then sank by 49.4% to $252.0 million in 2023, then soared by 77.38% to $447.0 million in 2024, then slumped by 89.93% to $45.0 million in 2025, then jumped by 548.89% to $292.0 million in 2026.
• The last three Short-term Investments figures came in at $292.0 million (Q2 2026), $375.0 million (Q1 2026), and $45.0 million (Q3 2025), per Business Quant data.